DOI:
10.1055/s-00000146
Diabetes aktuell
LinksClose Window
References
Vaccaro O, Masulli M, Nicolucci A. et al
Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial.
Lancet Diabetes Endocrinol 2017;
5: 887-897 doi:10.1016/S2213-8587(17)30317-0
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.